季铵化壳聚糖/肝素聚电解质多层膜用于蛋白质传递。
Quaternized Chitosan/Heparin Polyelectrolyte Multilayer Films for Protein Delivery.
机构信息
Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square 2, 162 06 Prague, Czech Republic.
Department of Physical Chemistry and Biophysics, Pharmaceutical Faculty, Wroclaw Medical University, Borowska 211, 50-556 Wrocław, Poland.
出版信息
Biomacromolecules. 2022 Nov 14;23(11):4734-4748. doi: 10.1021/acs.biomac.2c00926. Epub 2022 Oct 26.
Layer-by-layer (LbL) polyelectrolyte coatings are intensively studied as reservoirs of bioactive proteins for modulating interactions between biomaterial surfaces and cells. Mild conditions for the incorporation of growth factors into delivery systems are required to maintain protein bioactivity. Here, we present LbL films composed of water-soluble -[(2-hydroxy-3-trimethylammonium)propyl] chitosan chloride (HTCC), heparin (Hep), and tannic acid (TA) fabricated under physiological conditions with the ability to release heparin-binding proteins. Surface plasmon resonance analysis showed that the films formed on an anchoring HTCC/TA bilayer, with TA serving as a physical crosslinker, were more stable during their assembly, leading to increased film thickness and increased protein release. X-ray reflectivity measurements confirmed intermixing of the deposited layers. Protein release also increased when the proteins were present as an integral part of the Hep layers rather than as individual protein layers. The 4-week release pattern depended on the protein type; VEGF, CXCL12, and TGF-β1 exhibited a typical high initial release, whereas FGF-2 was sustainably released over 4 weeks. Notably, the films were nontoxic, and the released proteins retained their bioactivity, as demonstrated by the intensive chemotaxis of T-lymphocytes in response to the released CXCL12. Therefore, the proposed LbL films are promising biomaterial coating candidates for stimulating cellular responses.
层层(LbL)聚电解质涂层作为生物活性蛋白质的储库受到了广泛的研究,可用于调节生物材料表面与细胞之间的相互作用。为了保持蛋白质的生物活性,需要将生长因子温和地整合到递药系统中。在这里,我们展示了由水溶性 -[(2-羟基-3-三甲基铵基)丙基]壳聚糖氯化物(HTCC)、肝素(Hep)和鞣酸(TA)组成的 LbL 薄膜,这些薄膜是在生理条件下制备的,具有释放肝素结合蛋白的能力。表面等离子体共振分析表明,在作为物理交联剂的 TA 存在的情况下,在 HTCC/TA 双层上形成的薄膜在组装过程中更加稳定,导致薄膜厚度增加和蛋白质释放增加。X 射线反射率测量证实了沉积层的混合。当蛋白质作为 Hep 层的组成部分而不是作为单个蛋白质层存在时,蛋白质的释放也会增加。4 周的释放模式取决于蛋白质类型;VEGF、CXCL12 和 TGF-β1 表现出典型的高初始释放,而 FGF-2 则在 4 周内持续释放。值得注意的是,这些薄膜是无毒的,释放的蛋白质保持其生物活性,这可通过 T 淋巴细胞对释放的 CXCL12 的强烈趋化作用得到证明。因此,所提出的 LbL 薄膜是有前途的生物材料涂层候选物,可用于刺激细胞反应。